Complete tumor eradication with cell therapies depends on persistence of donor CAR-cells in the patient
@klebanofflab.bsky.social show that deletion of Fas on donor CAR-T/CAR-NK improves persistence in FasL-dependent (host NK & T) manner @natcancer.nature.com
www.nature.com/articles/s43...
